{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 443491891
| IUPAC_name = 1-[4-(4-Chlorophenyl)-2-(2,6-dichlorophenyl)sulfanylbutyl]imidazole
| image = Butoconazole.svg

<!--Clinical data-->
| tradename = Gynazole-1, Mycelex-3
| Drugs.com = {{drugs.com|monograph|butoconazole}}
| MedlinePlus = a682012
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = C
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = OTC
| legal_status =
| routes_of_administration = Vaginal cream

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 67085-13-6
| ATC_prefix = G01
| ATC_suffix = AF15
| PubChem = 47472
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00639
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 43192
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 0Q771797PH
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D00880
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 3240
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1295

<!--Chemical data-->
| C=19 | H=17 | Cl=3 | N=2 | S=1
| molecular_weight = 411.776 g/mol
| smiles = Clc1ccc(cc1)CCC(Sc2c(Cl)cccc2Cl)Cn3ccnc3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H17Cl3N2S/c20-15-7-4-14(5-8-15)6-9-16(12-24-11-10-23-13-24)25-19-17(21)2-1-3-18(19)22/h1-5,7-8,10-11,13,16H,6,9,12H2
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = SWLMUYACZKCSHZ-UHFFFAOYSA-N
}}

'''Butoconazole''' (trade names '''Gynazole-1''', '''Mycelex-3''') is an [[imidazole]] [[Antifungal medication|antifungal]] used in [[gynecology]]. It is administered as a vaginal cream.<ref>{{cite journal
| last1 = Seidman | first1 = L. S.
| last2 = Skokos | first2 = C. K.
| title = An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis
| journal = Infectious diseases in obstetrics and gynecology
| volume = 13
| issue = 4
| pages = 197–206
| year = 2005
| doi = 10.1080/10647440500240615
| pmid = 16338779
| pmc =1784583
| doi-broken-date = 2017-01-24
}}</ref><ref>Butoconazole {{drugs.com|monograph|butoconazole}}</ref>
== Synthesis ==
[[File:Butoconazole synthesis.svg|thumb|center|500px|Butoconazole synthesis:<ref>{{cite journal|doi=10.1021/jm00206a028|pmid=357722|title=1-[4-(4-Chlorophenyl)-2-(2,6-dichlorophenylthio)-n-butyl]-1H-imidazole nitrate, a new potent antifungal agent|journal=Journal of Medicinal Chemistry|volume=21|issue=8|pages=840|year=1978|last1=Walker|first1=Keith A. M.|last2=Braemer|first2=Allen C.|last3=Hitt|first3=Sharon|last4=Jones|first4=Richard E.|last5=Matthews|first5=Thomas R.}}</ref> Keith A. M. Walker {{US patent|4078071}} (1978 to [[Syntex]])]]
Reaction of [[epichlorohydrin]] with 4-chlorophenylbenzylmganeium chloride leads to 1-chloro-4-(4-chlorophenyl)butan-2-ol ('''3'''). Displacement with sodium imidazole, conversion of the secondary alcohol to the chloride ([[SOCl2]]), and displacement with 2,6-dichlorobenzenethiol concludes the synthesis of the antifungal butoconazole.

== References ==
{{reflist}}

{{Gynecological anti-infectives and antiseptics}}
{{Antifungals}}

[[Category:Chloroarenes]]
[[Category:Thioethers]]
[[Category:Imidazole antifungals]]
[[Category:Lanosterol 14α-demethylase inhibitors]]


{{genito-urinary-drug-stub}}
{{antimicrobial-stub}}